University of Oklahoma at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
University of Oklahoma brings 4 presentations to ObesityWeek 2026 in National Harbor. Its program centers on lab studies of muscle and liver metabolism, including how removing MIRO1 from muscle protects against liver fibrosis and how liver UCP2 controls energy use. It also reports more than additive weight loss from combining melanocortin receptor agonism with phentermine/topiramate.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
University of Oklahoma Norman, OK | |
Public research university in Norman, Oklahoma. | Talk Sat Nov 14 1:15pm–1:30pm Poster Sat Nov 14 7:30pm–8:30pm Thermoneutrality Unmasks Hepatocyte-Specific UCP2-Dependent Control of Energy Expenditure, Substrate Utilization, and Adiposity Metabolism and integrative physiology Poster Sun Nov 15 2:30pm–3:30pm Super-Additive Weight Loss From Combining Melanocortin Receptor Agonism With Phentermine/Topiramate Obesity pharmacotherapy and drug developmentClinical obesity care and professional practice Poster Mon Nov 16 2:30pm–3:30pm Sex-Specific Predictors of Muscle Function in Older Adults With Obesity Pediatric and adolescent obesityObesity pharmacotherapy and drug development |
Find decision makers at University of Oklahoma
Tell us what you sell and we’ll find the people at University of Oklahoma most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction